PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 23, 20261 citations

Almond for mild to moderate Alzheimer's disease: A randomized clinical trial.

View Full Paper
MMMohsen MohajeriIran University of Medical SciencesFHFataneh Hashem-DabaghianIran University of Medical SciencesSRShima RaeesiDouglas College

Key Points

  • The aim is to evaluate the effectiveness of almonds as an intervention for enhancing memory and sleep in Alzheimer's disease patients.
  • Conducted a randomized clinical trial
  • Assessed memory and sleep enhancement in participants with mild to moderate Alzheimer's disease
  • Recommended further studies with larger samples and longer follow-up periods
  • Almond is considered a probably safe intervention for memory enhancement.
  • Potential benefits observed for sleep enhancement in Alzheimer's disease patients.

Abstract

Almond is a probable safe intervention for memory and sleep enhancement in AD patients. Conducting studies with larger samples, longer follow-up periods, and different control groups are suggested.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mohajeri et al. (2026) studied this question.

synapsesocial.com/papers/69e9bc1285696592c86ed485https://doi.org/10.22038/ajp.2025.26297
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term effects of almond consumption on cognitive performance and brain vascular function: a randomized crossover trial in overweight/obese adults with prediabetes2026
  2. 2Non-pharmacological interventions for sleep improvement in Alzheimer's disease: A systematic review and meta-analysis2026
  3. 3Effectiveness of Nursing Strategies on Memory and Sleep Quality among Patients with Alzheimer’s Disease in a Selected Centers at Coimbatore2026
  4. 4Efficacy, safety, and response predictors of Astragalus in patients with mild to moderate Alzheimer's disease: A study protocol of an assessor-blind, statistician-blind open-label randomized controlled trial2024 · 3 citations
  5. 5Effectiveness of saffron in the treatment of mild to moderate Alzheimer’s disease with ADAS-cog score2024